APA 6th Edition Meregalli, E., Biggioggero, M., Borghi, O., Meroni, P. i Cimaz, R. (2005). In vivo Effects of Maternal Immunosupression during Pregnancy on the Immune Function of Newborn Infants. Arhiv za higijenu rada i toksikologiju, 56 (2), 151-156. Preuzeto s https://hrcak.srce.hr/143
MLA 8th Edition Meregalli, Elisa, et al. "In vivo Effects of Maternal Immunosupression during Pregnancy on the Immune Function of Newborn Infants." Arhiv za higijenu rada i toksikologiju, vol. 56, br. 2, 2005, str. 151-156. https://hrcak.srce.hr/143. Citirano 06.03.2021.
Chicago 17th Edition Meregalli, Elisa, Martina Biggioggero, Orietta Borghi, Pierluigi Meroni i Rolando Cimaz. "In vivo Effects of Maternal Immunosupression during Pregnancy on the Immune Function of Newborn Infants." Arhiv za higijenu rada i toksikologiju 56, br. 2 (2005): 151-156. https://hrcak.srce.hr/143
Harvard Meregalli, E., et al. (2005). 'In vivo Effects of Maternal Immunosupression during Pregnancy on the Immune Function of Newborn Infants', Arhiv za higijenu rada i toksikologiju, 56(2), str. 151-156. Preuzeto s: https://hrcak.srce.hr/143 (Datum pristupa: 06.03.2021.)
Vancouver Meregalli E, Biggioggero M, Borghi O, Meroni P, Cimaz R. In vivo Effects of Maternal Immunosupression during Pregnancy on the Immune Function of Newborn Infants. Arh Hig Rada Toksikol. [Internet]. 2005 [pristupljeno 06.03.2021.];56(2):151-156. Dostupno na: https://hrcak.srce.hr/143
IEEE E. Meregalli, M. Biggioggero, O. Borghi, P. Meroni i R. Cimaz, "In vivo Effects of Maternal Immunosupression during Pregnancy on the Immune Function of Newborn Infants", Arhiv za higijenu rada i toksikologiju, vol.56, br. 2, str. 151-156, 2005. [Online]. Dostupno na: https://hrcak.srce.hr/143. [Citirano: 06.03.2021.]
Sažetak When used in pregnancy, immunosuppressants can cross the placental barrier and enter foetal circulation, possibly affecting the immune system of the foetus. This study evaluated the immune function in eight children born by mothers with connective tissue diseases who received immunosuppressants (cyclosporine A or dexamethasone) during pregnancy and in six babies from mothers with similar diseases, but who did not receive any treatment. Judging by the cytokine production of interleukin-2 and interferon-γ in peripheral blood mononuclear cells stimulated by phorbol-myristate-acetate (PMA) and ionomycin, immunosuppressive drugs given for rheumatic disorders during pregnancy do not induce significant immunosuppression in babies.